Healthcare services company Select Medical (NYSE:SEM) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 20.9% year on year to $1.31 billion. The company’s full-year revenue guidance of $5.5 billion at the midpoint came in 9.1% below analysts’ estimates. Its GAAP loss of $0.13 per share was significantly below analysts’ consensus estimates.
Celsius (NASDAQ:CELH) Exceeds Q4 Expectations, Stock Jumps 23.8%
Energy drink company Celsius (NASDAQ:CELH) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales fell by 4.4% year on year to $332.2 million. Its non-GAAP profit of $0.14 per share was 44.2% above analysts’ consensus estimates.
The RealReal’s (NASDAQ:REAL) Q4 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Slightly Misses Expectations
Secondhand luxury marketplace The RealReal (NASDAQ: REAL) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 14.4% year on year to $164 million. The company expects next quarter’s revenue to be around $159 million, close to analysts’ estimates. Its non-GAAP loss of $0.01 per share was in line with analysts’ consensus estimates.
Texas Roadhouse (NASDAQ:TXRH) Surprises With Q4 Sales
Restaurant company Texas Roadhouse (NASDAQ:TXRH) announced better-than-expected revenue in Q4 CY2024, with sales up 23.5% year on year to $1.44 billion. Its GAAP profit of $1.73 per share was 5.4% above analysts’ consensus estimates.
Five9 (NASDAQ:FIVN) Exceeds Q4 Expectations, Stock Soars
Call center software provider Five9 (NASDAQ: FIVN) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 16.6% year on year to $278.7 million. The company expects next quarter’s revenue to be around $272 million, close to analysts’ estimates. Its non-GAAP profit of $0.47 per share was 33% below analysts’ consensus estimates.
BJ’s (NASDAQ:BJRI) Q4: Beats On Revenue, Stock Jumps 11.3%
American restaurant chain BJ’s Restaurants (NASDAQ:BJRI) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 6.4% year on year to $344.3 million. Its GAAP loss of $0.23 per share was significantly below analysts’ consensus estimates.
Rivian’s (NASDAQ:RIVN) Q4: Strong Sales
Electric vehicle manufacturer Rivian (NASDAQ:RIVN) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 31.9% year on year to $1.73 billion. Its non-GAAP loss of $0.46 per share was 28.1% above analysts’ consensus estimates.
Insulet’s (NASDAQ:PODD) Q4: Beats On Revenue, Quarterly Revenue Guidance Slightly Exceeds Expectations
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 17.2% year on year to $597.5 million. Guidance for next quarter’s revenue was better than expected at $545.5 million at the midpoint, 0.7% above analysts’ estimates. Its non-GAAP profit of $1.15 per share was 12.6% above analysts’ consensus estimates.
Sprouts (NASDAQ:SFM) Surprises With Q4 Sales
Grocery store chain Sprouts Farmers Market (NASDAQ:SFM) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 17.5% year on year to $2.00 billion. Its non-GAAP profit of $0.79 per share was 7.5% above analysts’ consensus estimates.
CarGurus (NASDAQ:CARG) Misses Q4 Sales Targets, Stock Drops
Online auto marketplace CarGurus (NASDAQ:CARG) fell short of the market’s revenue expectations in Q4 CY2024 as sales rose 2.4% year on year to $228.5 million. Next quarter’s revenue guidance of $226 million underwhelmed, coming in 5.2% below analysts’ estimates. Its non-GAAP profit of $0.55 per share was 6.2% above analysts’ consensus estimates.